The professional's guide to product selection
When coupled with the new variable valve technology (VVT) nebuliser chamber provided, the C28P produces a very small particle size with minimal prescribed solution residue, meaning more aerosol is available for inhalation over a shorter nebulisation time.
This model comes with the VVT nebuliser kit, tube, adult and child face masks, a mouthpiece, and five spare filters all packed inside a carry bag.
Stockists: Argos.
The vibrating mesh technology produces an extremely fine aerosol mist which penetrates quickly and deeply into the lungs. The MicroAir can be used at various angles, even lying down in bed.
The device is small and portable and provides four hours of nebulisation time from two AA batteries. With an average daily use of 30 minutes, this means it will last up to eight days.
Supplied complete with adult and child facemasks, mouthpiece, batteries and soft carrying pouch.
Stockists: Williams Medical Supplies, Evergreen Nebulisers.
The Omron UltraAir Pro U780 is intended for use in a medical facility, such as hospital, clinic and doctor’s office, or at home under the strict guidance of a medical expert.
The U780 is easy to clean, featuring a removable water tank that can be submerged in liquid for disinfection and cleaning purposes, a simple solution to a difficult cleaning concern. The attachments are also autoclave-safe giving a wider range of disinfectant options.
The unit operates completely silently and has easy touch controls to adjust the nebulisation volume and the air-flow.
Stockists: Evergreen Nebulisers.
Long-acting selective beta2 agonist.
• Over 18 years, by inhalation of powder: 150 mcg, once daily, increased to a maximum of 300 mcg once daily.
Lumacaftor increases the number of proteins that each the cell surface. Ivacaftor is a cystic fibrosis transmembrane conductance regulator (CFTR) protein potentiator that increases chloride transport in the abnormal CFTR protein.
By mouth using granules
Child 2–5 years (body-weight up to 14 kg): 100/125 mg every 12 hours.
Child 2–5 years (body-weight 14 kg and above): 150/188 mg every 12 hours.
By mouth using tablets
Child 6–11 years: 200/250 mg every 12 hours.
Child 12–17 years: 400/250 mg every 12 hours.
Adult: 400/250 mg every 12 hours – specialist use only.
Mucolytic
Osmohale is used for an indirect osmotic bronchial challenge test which can be used to identify bronchial hyperresponsiveness, a clinical feature of some respiratory conditions such as asthma.
Contraindications: Use with caution in renal impairment and to avoid in pregnancy. The Osmohale test should not be used in patients below 6 years of age due to their inability to provide reproducible spirometric measurements.
There is limited information on the use of Osmohale in patients 6-18 years of age therefore Osmohale is not recommended in this population.
Dose: See manufacturers’ instructions for more information. The test should be repeated until the patient has a positive response or 635 mg has been administered.
Long-acting selective beta2 agonist.
Oxis
By inhalation of powder for chronic asthma
• 6–17 years: 6–12 micrograms 1–2 times a day (max. per dose 12 micrograms), occasionally doses up to the maximum daily may be needed, reassess treatment if additional doses required on more than 2 days a week; maximum 48 micrograms per day.
• Adult: 6–12 micrograms 1–2 times a day, increased if necessary up to 24 micrograms twice daily (max. per dose 36 micrograms), occasionally doses up to the maximum daily may be needed, reassess treatment if additional doses required on more than 2 days a week; maximum 72 micrograms per day.
By inhalation of powder for relief of bronchospasm
• Over 6 years: 6–12 mcg up to twice daily
By inhalation of powder for prophylaxis of exercise-induced asthma
• Over 6 years: 6–12 mcg before exercise
• Adult: 12 mcg before exercise
By inhalation powder for COPD
• Adult: 12 micrograms 1–2 times a day (max. per dose 24 micrograms), for symptom relief additional doses up to maximum daily dose can be taken; maximum 48 micrograms per day.